newsfilter
← Latest News
Business Wire·

TYME Technologies, Inc. to Present at H.C. Wainwright Bioconnect Virtual Conference

TYME Technologies, Inc. (NASDAQ:TYME) (the Company or TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), today announced that Richie Cunningham, Chief Executive Officer, and Jonathan Eckard, Chief Business